Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease [NA]

View source ↗

Summary

A clinical trial is evaluating the effectiveness of the PET/CT tracer 68Ga-grazytracer for inflammatory bowel disease, with the study currently NOT_YET_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 68Ga-grazytracer

Snippet

Sponsor: Xijing Hospital | Conditions: Inflammatory Bowel Diseases (IBD) | NA | Status: NOT_YET_RECRUITING